Compare Novo Nordisk A/S (NVO) vs IAC/Interactivecorp (PPLI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novo Nordisk A/S vs IAC/Interactivecorp — how do they compare? Novo Nordisk A/S trades at $45.96 (market cap $207.85B), while IAC/Interactivecorp trades at $40.35 (market cap $2.97B). The key difference: Novo Nordisk A/S is far larger — about 70× IAC/Interactivecorp's market cap, and Novo Nordisk A/S pays a 3.81% dividend while IAC/Interactivecorp pays none. Which is the better fit depends on your goals.
| NVO | PPLI | |
|---|---|---|
Market Cap | $207.85B | $2.97B |
Sector | Health | Media |
52-Week High | $63.98 | $47.62 |
52-Week Low | $35.29 | $31.52 |
Enterprise Value | $222.55B | $3.28B |
Dividend Yield | 3.81% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Novo Nordisk A/S
With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 15% of revenue) that specializes in protein therapies for hemophilia and other disorders.
Read more on NVO →About IAC/Interactivecorp
IAC Inc is an Internet media company with segments that include Angi (47% of total revenue), Dotdash (10%), search (24%), and emerging and other (19%). The firm spun off the narrow-moat dating app provider Match Group in second-quarter 2020 and the no-moat video software provider Vimeo in second-quarter 2021.
Read more on PPLI →
